🇺🇸 Doxylamin in United States

13 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Accidental Overdose — 2 reports (15.38%)
  2. Intentional Overdose — 2 reports (15.38%)
  3. Suicide Attempt — 2 reports (15.38%)
  4. Anorexia Nervosa — 1 report (7.69%)
  5. Atrial Fibrillation — 1 report (7.69%)
  6. Back Pain — 1 report (7.69%)
  7. Condition Aggravated — 1 report (7.69%)
  8. Drug Interaction — 1 report (7.69%)
  9. Drug Prescribing Error — 1 report (7.69%)
  10. Drug Screen Positive — 1 report (7.69%)

Source database →

Doxylamin in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Infectious Disease approved in United States

Frequently asked questions

Is Doxylamin approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Doxylamin in United States?

St. Petersburg Bekhterev Research Psychoneurological Institute is the originator. The local marketing authorisation holder may differ — check the official source linked above.